Joshua Silverman - Feb 19, 2025 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role: Director
Signature: /s/ Mitchell Arnold, attorney-in-fact
Stock symbol: PTPI
Transactions as of: Feb 19, 2025
Transactions value $: $0
Form type: 4
Date filed: 2/21/2025, 05:33 PM
Previous filing: Dec 2, 2024
Next filing: Jun 27, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PTPI	Common Stock	Award	$0	+1M	+8899.17%	$0.00	1.01M	Feb 19, 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date.

Content

Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date.